Corpus Intelligence IC Memo — MEMORIAL HOSPITAL WEST 2026-04-26 03:58 UTC
IC Memo — MEMORIAL HOSPITAL WEST
Investment Committee Memorandum | FL | 486 beds | Grade C | EBITDA uplift $54.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEMORIAL HOSPITAL WEST

CCN 100281 | BROWARD, FL | 486 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MEMORIAL HOSPITAL WEST is a 486-bed suburban community hospital in BROWARD, FL with $741.4M in net patient revenue and a 5.2% operating margin. The hospital serves a payer mix of 16.2% Medicare, 2.6% Medicaid, and 81.2% commercial.

Thesis: Platform Growth. Our ML models identify $54.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.2% to 12.6% (+736bps).

Net Revenue HCRIS$741.4M
Current EBITDA COMPUTED$38.5M
Operating Margin COMPUTED5.2%
Occupancy HCRIS76.8%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS14.5%
Distress Probability ML40.2%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
78
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 5.2% places it above the state median. Among 78 size-comparable peers (243-972 beds), the median margin is 5.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (243-972), prioritizing same-state peers. 78 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEMORIAL HOSPITAL WEST (Target)FL486$741.4M5.2%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
TAMPA GENERAL HOSPITALFL898$1.73B-9.3%
BAPTIST HOSPITALFL948$1.71B10.8%
MEMORIAL REGIONAL HOSPITALFL838$1.45B-20.7%
LEE MEMORIAL HOSPITALFL748$1.28B17.4%
SARASOTA MEMORIAL HOSPITALFL787$1.10B8.1%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
ASCENSION SACRED HEART PENSACOFL559$1.04B-10.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $54.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$15.6M+210bp18mo
Cost to Collect4.5%2.5%$14.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$14.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$9.0M+122bp9mo
Clean Claim Rate88.0%96.0%$474K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$15.6M
Cost to Collect
$14.8M
Denial Rate Reduction
$14.7M
A/R Days Reduction
$9.0M
Clean Claim Rate
$474K
Total EBITDA Uplift$54.6M
Current EBITDA$38.5M
+ RCM Uplift+$54.6M
Pro Forma EBITDA$93.1M
Current Margin5.2%
Pro Forma Margin12.6%
WC Released (1x)$28.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$59.2M$799.5M13.51x68.3%
Base (11x exit)10.0x11.0x$59.2M$898.7M15.18x72.3%
Bull Case9.0x11.0x$53.3M$1.10B20.61x83.2%
Bull (12x exit)9.0x12.0x$53.3M$1.21B22.78x86.9%
Bear Case11.0x10.0x$65.1M$507.4M7.79x50.8%
Bear (11x exit)11.0x11.0x$65.1M$579.3M8.90x54.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 78 hospitals with 243-972 beds
  • Same-state prioritization (n=79)
  • Comp margins: P25=-5.0% / P50=5.0% / P75=18.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.